38 results on '"Yarom, Nirit"'
Search Results
2. Single-Fraction Celiac Plexus Radiosurgery: A Preliminary Proof-of-Concept Phase 2 Clinical Trial
3. Topical doxycycline foam 4% for prophylactic management of epidermal growth factor receptor inhibitor skin toxicity: an exploratory phase 2, randomized, double-blind clinical study
4. Process of drug registration in Israel: the correlation between the number of discussions within the Ministry of Health and postapproval variations by EMA and/or FDA
5. Combination treatment of intratumoral vidutolimod (CMP-001), radiosurgery, nivolumab, and ipilimumab for metastatic colorectal carcinoma.
6. Nuclear Export Inhibition for Radiosensitization: A Proof-of-Concept Phase 1 Clinical Trial of Selinexor (KPT-330) Combined With Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer
7. A comparative study on two different pathological methods to retrieve lymph nodes following gastrectomy
8. Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease
9. Neoadjuvant Chemohormonal Therapy in Poor-Prognosis Localized Prostate Cancer
10. Phase I Clinical Trial of Exherin (ADH-1) in Patients with Advanced Solid Tumors
11. A phase II study of siG12D-LODER in combination with chemotherapy in patients with locally advanced pancreatic cancer (PROTACT).
12. KRAS Status as a Predictor of Chemotherapy Activity in Patients With Metastatic Colorectal Cancer
13. Epistaxis during Treatment with Paclitaxel
14. Progression after docetaxel-based chemotherapy in androgen-independent prostate cancer
15. Single-shot celiac plexus radiosurgery in pancreatic cancer: Palliative and functional outcomes—Final results of a prospective clinical trial.
16. Mutant allele-specific imbalance in patients with metastatic colorectal cancer.
17. Gastroenteropancreatic neuroendocrine tumors (GEP-NETs): clinico-pathological characteristics and disease outcome of 110 patients treated at single referral medical center
18. Safety and activity of topical 4% doxycycline foam (FDX104) in epidermal growth factor receptor inhibitor (EGFRI) induced skin toxicity.
19. Treatments and clinical outcomes in stage II colon cancer (CC) patients (pts) with 12-gene Oncotype DX Colon Recurrence Score assay-guided therapy: Real-world data.
20. Colon cancer in immigrants from Ethiopia.
21. Phase II study of neoadjuvant irinotecan, capecitabine, oxaliplatin (IXO) followed by chemoradiotherapy (CRT) using concurrent capecitabine for resectable locally advanced rectal cancer.
22. Anti-EGFR monoclonal antibodies (MAb) combined with chemotherapy in metastatic colon cancer (mCRC) patients (pts): Meta-analysis of randomized trials.
23. Impact of KRAS mutational status on clinical outcomes in patients receiving capecitabine based chemotherapy.
24. D1 versus D2 Gastrectomy for Gastric Adenocarcinoma.
25. Colorectal cancer (CRC) KRAS mutational status and response to chemotherapy in absence of influence of epidermal growth factor receptor (EGFR) monoclonal antibody (MAb) therapy.
26. IXOA regimen, irinotecan (I), capecitabine (X), oxaliplatin (O), and bevacizumab (A), as first-line therapy for advanced unresectable colorectal cancer (aCRC): Preliminary results.
27. Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease
28. EGFR expression variance in paired colorectal cancer primary and metastatic tumors
29. The Epidermal Growth Factor Receptor in Colon Cancer; a Prognostic, Predictive Marker or a Target for Therapy?
30. A similar cell-specific pattern of HOXA methylation in normal and in cancer tissues
31. Extracellular Signal-Regulated Kinase 1c (ERK1c), a Novel 42-Kilodalton ERK, Demonstrates Unique Modes of Regulation, Localization, and Function
32. Colorectal Cancer: OVERALL SURVIVAL IN MCRC.
33. Updates in adjuvant systemic therapy for colon cancer.
34. [GERIATRIC ONCOLOGY - CANCER TREATMENT IN OLDER ADULTS AND OLDEST-OLD].
35. Correction for Aebersold et al., "Extracellular Signal-Regulated Kinase 1c (ERK1c), a Novel 42-Kilodalton ERK, Demonstrates Unique Modes of Regulation, Localization, and Function".
36. ADH-1 in the treatment of metastatic adrenocortical carcinoma--case report.
37. The role of the epidermal growth factor receptor in the mechanism and treatment of colorectal cancer.
38. [Taxotere-based chemotherapy in androgen-independent prostate cancer].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.